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Noncytopathic replicons of the flavivirus Kunjin (KUN) were employed for expression and delivery of heterologous genes.
Replicon vector C20DX2Arep, containing a unique cloning site followed by the sequence of 2A autoprotease of foot-and-
mouth disease virus, was constructed and used for expression of a number of heterologous genes including chloramphenicol
acetyltransferase (CAT), green fluorescent protein (GFP), b-galactosidase, glycoprotein G of vesicular stomatitis virus, and
the Core and NS3 genes of hepatitis C virus. The expression and proper processing of these genes upon transfection of
BHK21 cells with the recombinant replicon RNAs were demonstrated by immunofluorescence, radioimmunoprecipitation, and
appropriate reporter gene assays. Most of these recombinant KUN replicon RNAs were also successfully packaged into
secreted virus-like particles (VLPs) by subsequent transfection with Semliki Forest virus replicon RNA expressing KUN
structural genes. Infection of BHK21 and Vero cells with these VLPs resulted in continuous replication of the recombinant
replicon RNAs and prolonged expression of the cloned genes without any cytopathic effect. We also developed a replicon
vector for generation of stable cell lines continuously expressing heterologous genes by inserting an encephalomyelocarditis
virus internal ribosomal entry site-neomycin transferase gene cassette into the 39-untranslated region of the C20DX2Arep
vector. Using this vector (C20DX2ArepNeo), stable BHK cell lines persistently expressing GFP and CAT genes for up to 17
passages were established. Thus noncytopathic KUN replicon vectors with the ability to be packaged into VLPs should
provide a useful tool for the development of noninfectious and noncytopathic vaccines as well as for gene therapy
applications. © 1999 Academic Press
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1INTRODUCTION
Systems for expression of heterologous genes in
ammalian cells based on self-replicating RNAs (repli-
ons) of positive-strand RNA viruses including alphavi-
uses Semliki Forest virus (SFV) (Liljestrom and Garoff,
991; Zhou et al., 1994), Venezuelan equine encephalitis
irus (VEE) (Pushko et al., 1997), and Sindbis virus (SIN)
Bredenbeek et al., 1993; Johanning et al., 1995; Kamrud
t al., 1995; Xiong et al., 1989), as well as poliovirus (Choi
t al., 1991; Percy et al., 1992; Porter et al., 1993, 1995;
nsardi et al., 1993) replicons are now available. The
uccess of these expression systems is based on a high
evel of expression, easy construction of recombinants,
nd the ability to produce high-titer stocks of pseudoin-
ectious particles containing recombinant replicon RNA
ackaged by the structural proteins supplied from co-
ransfected helper RNA. Packaged alphavirus replicons
ave been successfully utilized for vaccination against
icrobial and viral pathogens (Zhou et al., 1994; Pushko
t al., 1997). The main advantage of using packaged
eplicon vectors for vaccine delivery is that no additional
nfectious particles can be produced to spread to other
1 To whom correspondence and reprint requests should be ad-
aressed. Fax: (617) 3253 1401. E-mail: a.khromykh@mailbox.uq.edu.au.
042-6822/99 $30.00
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366issues after replication and expression of heterologous
enes in initially infected cells. However, there are two
ajor problems associated with alphavirus and poliovi-
us replicon systems. First, a severe cytopathic effect is
bserved during replication of alphavirus and poliovirus
eplicons in cells, resulting in only a short-term transient
xpression. Second, a possibility of contamination of
ackaged alphavirus replicon stocks with infectious vi-
us, due to recombination between the replicon and
elper RNAs (Life Technologies Inc., 1994; Frolov et al.,
997; Raju et al., 1995), cannot be excluded. One of these
roblems (cytopathicity) was recently overcome by prep-
ration of the noncytopathic SIN replicon vectors
Agapov et al., 1998). However, these vectors have at
resent a limited range of cell lines in which they can be
sed and no data were presented on the ability of these
eplicons to be packaged.
Recently we described the preparation of flavivirus
unjin (KUN) replicon RNA (Khromykh and Westaway,
997) and its encapsidation by using a heterologous
ackaging system where KUN structural proteins were
upplied in trans from the cotransfected recombinant
FV replicon RNA (Khromykh et al., 1998a). Significantly,
o replicating SFV or recombined KUN-SFV RNAs were
etected in the encapsidated particles (Khromykh et al.,
998a), thus indicating the specificity of KUN RNA pack-
ging as well as the absence of recombination between
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367KUNJIN REPLICON GENE EXPRESSION AND DELIVERY SYSTEMUN and SFV RNAs. Also, in contrast to alphavirus and
oliovirus replicons, replication of KUN replicon RNA in
ransfected cells was long-lasting and did not produce
ny cytopathic effect. Insertion of the internal ribosomal
ntry site (IRES) of encephalomyelocarditis virus (EMCV)
nd a neomycin transferase gene (Neo) cassette into the
9-untranslated region (UTR) of the KUN replicon ge-
ome allowed the establishment of a stable BHK cell line
ersistently expressing KUN-Neo replicon RNA after its
ransfection and subsequent selection of the expressing
ells with antibiotic G418 (geneticin) (Khromykh and
estaway, 1997).
In this study we constructed modified KUN replicon
ectors adapted for cloning of heterologous genes and
sed these vectors for expression of biologically func-
ional reporter genes chloramphenicol acetyltransferase
CAT), green fluorescent protein (GFP), and b-galactosi-
ase (b-gal), as well as glycoprotein G of vesicular sto-
atitis virus (VSV-G) and the Core and NS3 proteins of
epatitis C virus (HCV). Expression of these genes was
emonstrated either after electroporation of correspond-
ng recombinant replicon RNAs into BHK21 cells or after
FIG. 1. Schematic representation of the Kunjin replicon expression
erivatives. SP6 shows the position of the SP6 promoter. 59UTR an
orresponds to the first 20 amino acids of KUN Core protein. 22E corr
o the sequence coding for the KUN nonstructural proteins. 2A indicates
ts cleavage site indicated (Ryan et al., 1991; Ryan and Drew, 1994
ncephalomyelocarditis virus RNA followed by a sequence coding fo
ndicated position in the 39UTR to obtain C20DX2ArepNeo vector for st
nd Westaway, 1997)]. SpeI shows a unique restriction site for cloni
eterologous genes inserted into the SpeI site of the C20DX2Arep vecto
91 amino acids of hepatitis C virus Core protein, respectively; CAT, c
equence coding for amino acids 183 to 617 of hepatitis C virus NS3
tomatitis virus; b-gal, Escherichia coli b-galactosidase. The 1IRESNeo
nto the C20DX2ArepNeo vector. (C) Dicistronic C20DXIRESrep vector a
f a unique site for cloning of heterologous genes followed by the tranfection of BHK21 and Vero cells with KUN virus-like Farticles (VLPs) containing encapsidated recombinant
eplicon RNAs. We also demonstrate the use of a select-
ble noncytopathic KUN-Neo replicon vector for estab-
ishment of stable BHK cell lines continuously express-
ng CAT and GFP genes. The presented KUN replicon-
ased expression and delivery system can be used for
he development of a wide range of pseudoinfectious
nd noncytopathic vaccines against medically important
athogens, as well as in gene therapy.
RESULTS
onstruction of KUN replicon vectors and expression
f heterologous genes
To ensure cytosolic cleavage of heterologous genes ex-
ressed from the KUN replicon vectors, we modified our
20DXrep construct (Khromykh et al., 1998a) by inserting
he sequence coding for 2A autoprotease of foot-and-
outh disease virus (FMDV-2A) in between the sequences
or the first 20 amino acids of KUN Core (C20) protein and
he last 22 amino acids of KUN E protein, preserving the
UN polyprotein open reading frame [C20DX2Arep(Neo),
and recombinant constructs. (A) C20DX2Arep(Neo) vector(s) and its
R represent the 59 and 39 untranslated regions, respectively. C20
s to the last 22 amino acids of KUN E protein. NS1-NS5 corresponds
ence coding for 2A autoprotease of foot-and-mouth disease virus with
Neo represents a sequence of an internal ribosomal entry site of
eomycin transferase gene (Neo). This cassette was inserted at the
lection of replicon expressing cells [similar to DME/76Neo (Khromykh
eterologous genes. (B) A list of KUN replicons with corresponding
rCore and hcv-flCore represent sequences coding for the first 160 and
phenicol acetyltransferase; GFP, green fluorescent protein; hcv-NS3,
(Trowbridge and Gowans, 1998); VSV-G, glycoprotein G of vesicular
ligned with CAT and GFP indicates that these genes were also cloned
erivative construct C20DX/CAT/IRESrep. AscI–Stop shows the position
termination codon (Stop). The other abbreviations are as in (A).vectors
d 39UT
espond
a sequ
). IRES
r the n
able se
ng of h
r. hcv-t
hloram
protein
sign a
nd its dig. 1A]. FMDV-2A is a small 19-amino-acid peptide that
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368 VARNAVSKI AND KHROMYKHleaves itself at the C-terminus between the glycine–
roline dipeptide (Ryan et al., 1991) and has been success-
ully used to mediate cleavage of artificial polyproteins
Percy et al., 1994; Ryan and Drew, 1994). To facilitate clon-
ng of foreign genes (FGs), a unique cloning site SpeI was
ncorporated at the N-terminus of the FMDV-2A sequence
Fig. 1A). Thus, cloning into the SpeI site of this vector
hould result in expression of a product containing the
rotein of interest fused to the first 20 amino acids of the
UN C protein at its N-terminus and to the 17 amino acids
f FMDV-2A protease at its C-terminus (Fig. 1A). An alter-
ative dicistronic vector, C20DXIRESrep, which allowed ex-
ression of the C20/FG fusion protein with a precise C-
erminus, was also prepared by inserting a translation ter-
ination codon cassette with a unique AscI cloning site
AscI–(Stop)–IRES] directly after the C20 sequence (see Fig.
C).
To estimate the optimal times and levels of expression
f different heterologous products using this system we
nitially prepared KUN replicons expressing the reporter
enes CAT (218 amino acids), GFP (237 amino acids),
nd b-gal (1017 aa) (Fig. 1B). In addition, the CAT gene
as also inserted into the C20DXIRESrep vector (C20DX/
AT/IRESrep construct, Fig. 1C). To examine glycosyla-
ion of expressed glycoproteins in our system we also
repared construct C20DX/VSV-G/2Arep expressing VSV
glycoprotein (Fig. 1B). The expression of these genes
n BHK21 cells electroporated with corresponding re-
ombinant KUNrep RNAs (see Fig. 1) was demonstrated
y immunofluorescence (IF) analysis with specific anti-
odies to CAT and VSV-G proteins (Fig. 2A), by fluores-
ence analysis of live unfixed cells for GFP protein (GFP
anel in Fig. 2B), and by X-gal staining of the transfected
ells for b-gal protein (b-gal panel in Fig. 2B).
As a first step in development of a vaccine against
CV using the KUN replicon system, we cloned and
xpressed the Core and NS3 gene sequences of an
ustralian isolate of HCV (Trowbridge and Gowans,
998) in C20DX2Arep vector. The HCV NS3 gene se-
uence, coding for amino acids 183 to 617 (Trowbridge
nd Gowans, 1998) and containing a number of cytotoxic
-lymphocyte epitopes (Koziel, 1997), was cloned into the
20DX2Arep vector. Expression of the HCV NS3 gene
as detected in BHK21 cells transfected with the recom-
inant C20DX/hcvNS3/2Arep RNA using human anti-
CV serum (panel 2 in Fig. 2C). The HCV Core gene was
xpressed in two forms: as a full-length gene sequence,
oding for 191 amino acids (C20DX/hcv-flCore/2Arep
NA, panel 3 in Fig. 2C), and as a truncated sequence,
oding for the first 160 amino acids (C20DX/hcv-trCore/
Arep RNA, panel 4 in Fig. 2C). Electroporation of both
eplicon RNAs into BHK21 cells resulted in expression of
CV Core protein at similar levels, as judged by the
ntensity of IF with human anti-HCV serum (Fig. 2C,
anels 3 and 4). Significantly, similar to the reports on
xpression of different forms of HCV Core in other sys- iems (Suzuki et al., 1995; Lo et al., 1995), truncated HCV
ore expressed from the KUN replicon vector was local-
FIG. 2. Expression of heterologous genes in BHK21 cells electropo-
ated with recombinant RNAs. (A and C) IF analysis of BHK21 cells at
4 to 40 h after transfection with the recombinant KUN replicon RNAs
xpressing different heterologous genes (Fig. 1, as indicated under
ach panel) using corresponding antibodies. Dilutions of antibodies
ere as follows: 1/100 for rabbit anti-CAT polyclonal antibodies (panels
and 2 in A); 1/150 for rabbit anti-VSV-G polyclonal antibodies (panels
and 4 in A); 1/40 for human anti-HCV polyclonal serum (panels 1–4 in
). Mocks represent parallel IF analyses of untransfected BHK21 cells
ith corresponding antibodies in (A) and anti-HCV antibodies in (C). (B)
FP panel shows fluorescence of live unfixed BHK21 cells at 24 h after
ransfection with C20DX/GFP/2Arep RNA. b-gal panel represents X-gal
taining of BHK21 cells at 46 h after transfection with C20DX/b-gal/
Arep RNA performed as described under Materials and Methods.zed in the nuclei, while full-length Core was not.
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369KUNJIN REPLICON GENE EXPRESSION AND DELIVERY SYSTEMinetics of expression, processing, and glycosylation
f heterologous proteins using KUN replicon vectors
The expression kinetics of two reporter genes, CAT
218 amino acids) and b-gal (1017 amino acids), after
lectroporation of the corresponding recombinant KUN-
ep RNAs into BHK21 cells were compared using the
ppropriate reporter gene assays. Similar to our previous
esults on replication of KUNrep RNA (Khromykh et al.,
998a), a delay of about 10–16 h in detectable expression
f both reporter genes was observed (Fig. 3). Further
ncubation of electroporated cells resulted in a rapid
ccumulation of CAT protein, reaching its maximum at
30 h after transfection (Fig. 3A), while accumulation of
-gal protein was slightly delayed, reaching a maximum
t ;36–40 h after transfection (Fig. 3B). In parallel ex-
eriments, the levels of expression of CAT and b-gal
enes from alphavirus replicons SIN (TRCAT) and SFV
SFV3/LacZ), respectively, were similar to those obtained
rom the corresponding KUN replicons (C20DX/CAT/
Arep and C20DX/b-gal/2Arep), in cells electroporated
ith the same amounts of RNA. However, the levels of
FIG. 3. Time course analyses of CAT and b-gal protein expression i
omparative analysis of CAT expression in BHK21 cells at indicated
C20DX/CAT/2Arep) or Sindbis replicon (TRCAT) RNAs. CAT activity is
iquid scintillation count CAT assay of the cell lysates as described u
-galactosidase accumulation in BHK21 cells transfected with the sam
NAs. Amounts of b-gal produced in electroporated BHK21 cells were d
ysates with known b-galactosidase enzyme standards, using a b-Galac
see Materials and Methods). (C) X-gal staining of BHK21 cells at 37 h
FV3/LacZ (SFV) replicon RNAs. Note severe CPE in SFV replicon-tranxpression from alphavirus replicons reached their max- ;mum earlier (compared to KUN replicons) after electro-
oration (7–10 h, Figs. 3A and 3B). Quantitative analysis
f b-gal expression showed that ;6.5 and ;7.5 mg of
-gal protein per 106 initially transfected BHK21 cells
ere produced from ;5 mg of electroporated C20DX/b-
al/2Arep and SFV3/LacZ RNAs, respectively (Fig. 3B).
mportantly, in contrast to the cells transfected with
FV3/LacZ RNA that exhibited a strong cytopathic effect
CPE), the cells transfected with KUN C20DX/b-gal/2Arep
NA appeared healthy (Fig. 3C).
To examine whether correct proteolytic cleavage me-
iated by FMDV-2A protease occurred during translation
f recombinant KUN replicon RNAs in electroporated
ells, we analyzed the sizes of the radiolabeled protein
roducts expressed from C20DX/CAT/2Arep RNA by us-
ng radioimmunoprecipitation analysis of cell lysates
ith anti-CAT antibodies. A strong radiolabeled band of
30 kDa, corresponding to a predicted size of C20/
AT/2A fusion protein (257 amino acids), was observed
lane 1, Fig. 4A), suggesting that FMDV-2A cleavage in-
eed occurred. The presence of a very weak band of
transfected with corresponding recombinant KUN replicon RNAs. (A)
after transfection with the same amounts (;5 mg) of KUN replicon
sed in cpm of radioactive acetylated chloramphenicol, determined by
aterials and Methods. (B) Comparative analysis at indicated times of
nts (;5 mg) of KUN (C20DX/b-gal/2Arep) or SFV (SFV3/LacZ) replicon
ned by comparison of corresponding OD420 readings for the tested cell
se Enzyme Assay System (Promega) as described by the manufacturer
ransfection with the same amounts of C20DX/b-gal/2Arep (KUN) and
cells but not in KUN replicon-transfected cells.n cells
times
expres
nder M
e amou
etermi
tosida
after t33 kDa, corresponding to the predicted size of C20/
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370 VARNAVSKI AND KHROMYKHAT/2A/22E fusion protein (286 amino acids), was also
bserved (lane 1, Fig. 4A), indicating that the cleavage by
MDV-2A protease was not complete. However, compar-
tive analysis of the relative intensities of these two
ands clearly demonstrated that almost all of the fusion
rotein (;95–98%) was efficiently cleaved. Note that the
leavage between 22E (functioning as a signal se-
uence) and NS1 (Fig. 1A) is mediated by cellular signal
eptidase (Coia et al., 1988). Expression and proper
rocessing of heterologous genes from the dicistronic
UN replicon vector C20DXIRESrep were demonstrated
y detection of an ;27.5-kDa band corresponding to the
redicted size of the C20/CAT fusion protein (240 amino
cids) in the anti-CAT immunoprecipitate from the lysate
f BHK21 cells transfected with C20DX/CAT/IRESrep
NA (lane 2, Fig. 4A).
Glycosylation of the VSV-G protein expressed from the
UN replicon was demonstrated by the observed reduc-
ion in size of the endoglycosidase F treated (compared
o untreated) VSV-G protein sample, precipitated with
nti-VSV-G antibodies from the radiolabeled lysates of
HK21 cells transfected with C20DX/VSV-G/2Arep RNA
FIG. 4. Processing of polyproteins translated from electroporated rec
HK21 cells transfected with C20DX/CAT/2Arep (lane 1), C20DX/CAT/I
0-mm-diameter tissue culture dishes of BHK21 cells at 46 h after
35S]methionine–cysteine for 5 h and RIP analysis of cell lysates was p
1/100 dilution of anti-CAT antibodies. Samples recovered after RIP an
ots show the positions of corresponding CAT fusion protein products
ells electroporated with C20DX/VSV-G/2Arep (lanes 1 and 2) and C20D
t 33 h after electroporation were labeled with ;50 mCi of [35S]methi
ne-half (10 ml) of the C20DX/VSV-G/2Arep RIP sample was treated wi
nd both endo F-treated and untreated samples were electrophoresed
lycosylated (gVSV-G) and nonglycosylated (VSV-G) proteins. The mo
nserted (CAT of VSV-G) genes.compare lanes 1 and 2 in Fig. 4B). cackaging of recombinant KUN replicon RNAs into
seudoinfectious virus-like particles
A relatively high level of expression of heterologous
enes was achieved after electroporation of the corre-
ponding recombinant KUN replicon RNAs into BHK21
ells. However, the efficiency of transfection, as a gen-
ral method of gene delivery, varies tremendously
mong different cell lines. This problem could possibly
e overcome by delivery of recombinant replicon RNAs
nto cells via infection with encapsidated VLPs. Recently
e developed a heterologous packaging system allow-
ng production of such VLPs containing KUN replicon
NA encapsidated by the KUN structural proteins using
onsecutive transfections with KUN replicon RNA and
FV replicon RNA SFV-prME-C105 expressing KUN
tructural genes (Khromykh et al., 1998a). The highest
iter of VLPs was achieved when the second electropo-
ation with SFV-prME-C105 RNA was performed at the
ime of maximum replication of KUN replicon RNA (using
delay of ;24–27 h) (Khromykh et al., 1998a). Therefore
n packaging experiments with recombinant KUN repli-
nt KUN replicon RNAs. (A) Radioimmunoprecipitation (RIP) analysis of
(lane 2), and C20DX2Arep (lane 3) RNAs using anti-CAT antibodies.
poration with corresponding RNAs were labeled with ;100 mCi of
ed essentially as described previously (Khromykh et al., 1998a) using
ere electrophoresed on a 12.5% SDS–polyacrylamide gel. Arrows and
P analysis with rabbit anti-VSV-G antibodies (1/100 dilution) of BHK21
p (lane 3) RNAs. 60-mm-diameter tissue culture dishes of BHK21 cells
cysteine for 8 h and the cell lysates were subjected to RIP analysis.
glycosidase F (endo F) as described elsewhere (Falgout et al., 1989),
10% SDS–polyacrylamide gel. Arrows and dots show the positions of
s in (A) and (B) contain samples obtained using a replicon with noombina
RESrep
electro
erform
alysis w
. (B) RI
X2Are
onine–
th endo
on a
ck laneon RNAs, a second electroporation with SFV-prME-
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371KUNJIN REPLICON GENE EXPRESSION AND DELIVERY SYSTEM105 RNA was performed at the experimentally deter-
ined time of maximum replication of the corresponding
ecombinant KUN replicon RNAs (for time intervals used
ee the legend to Fig. 5).
Essentially all the different recombinant replicon RNAs
ere packaged into VLPs and secreted as infectious
nits, although with different efficiencies. The lowest
fficiency of packaging was obtained for replicon RNAs
oding for HCV Core protein [less than 103 infectious
nits per milliliter of culture fluid (IU/ml, Table 1)], sug-
esting strong interference of the HCV Core gene se-
uence or its protein product with the encapsidation of
ecombinant KUN replicon RNA. The titers of extracellu-
ar VLPs recovered in the packaging experiments with
ther recombinant RNAs were all in the range of 105–106
U/ml depending on the type of cells used for infectivity
ssay (Vero or BHK21), inserted sequence, and possibly
he initial transfection efficiency (Fig. 5; Table 1). Note
hat the higher initial transfection efficiency obtained in
he second experiment with C20DX/GFP/2Arep RNA re-
ulted in a corresponding increase in titer of the secreted
FIG. 5. Packaging of recombinant KUN replicon RNAs expressing re
nd IF analyses of BHK21 and Vero cells at 35 h after infection with cultu
UN replicon RNAs and SFV-prME-C105 RNA (Khromykh et al., 1998a
ransfections were 30 h for C20DX/GFP/2Arep, 34 h for C20DX/VSV-G/2
ulture fluid after second transfections with SFV-prME-C105 RNA were 2
rom BHK21 cells (BHK mock) or BHK21 cells at 30 h after infection wit
nitially with C20DX/CAT/2Arep RNA and 26 h later with SFV-prME-C
oncentrated culture fluid collected from BHK21 cells at 30 h after d
FV-prME-C105 RNA. Culture fluid was concentrated by ultracentrifug
entrifuge through a 20% sucrose cushion. CAT assay in (B) and X-galporter (CAT, GFP, b-gal), VSV-G, and HCV NS3 genes. (A) GFP fluorescence
re fluid collected from BHK21 cells sequentially transfected with recombinant
) using the corresponding antibodies as indicated. Time intervals between
Arep, and 42 h for C20DX/hcv-NS3/2Arep RNAs; time intervals for harvesting
4, 37, and 38 h, respectively. (B) Autoradiogram of the CAT assay of the lysates
h the culture fluid collected from BHK21 cells at 42 h after dual transfections,
105 RNA. (C) X-gal staining of BHK21 cells 42 h after infection with the
ual transfections, initially with C20DX/b-gal/2Arep RNA and 37 h later with
ation at 40,000 rpm for 4 h at 4°C in the AH650 rotor of Sorvall OTD55BLPs compared to that obtained in the first experiment sTABLE 1
Titers of Secreted Recombinant VLPs Containing
Encapsidated KUN Replicon RNA
Replicon constructs
Efficiency of initial
transfection
(% positive cells)a
Titer, 3 105 (IU/ml)b
Vero BHK21
20DX/GFP/2Arep (exp. 1) 30–40 18 12
20DX/GFP/2Arep (exp. 2) 70–80 nt 55
20DX/hcv-NS3/2Arep 30–40 nt 1.2
20DX/VSV-G/2Arep 15–20 3.4 1
20DX/CAT/2Arep 15–20 2 1.6
20DX/b-gal/2Arep 15–20 1 1
20DX/hcv-trCore/2Arep 60–70 nt ,0.01
20DX/hcv-flCore/2Arep 60–70 nt ,0.01
Note. nt, not tested.
a Efficiencies of initial transfection were estimated by IF analysis of
ells transfected with corresponding RNAs using KUN anti-NS3 anti-
odies as described under Materials and Methods.
b Titers [infectious units (IU)] were determined by counting IF-posi-
ive or X-gal stained Vero or BHK21 cells after infection with appropriate
ilutions of corresponding VLPs as described previously (Khromykh et
l., 1998a). VLPs used for infection were harvested at 24–38 h after a
econd transfection (see text).
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372 VARNAVSKI AND KHROMYKHTable 1). This result indicates that improvement in the
nitial transfection efficiency that may be achieved by
ppropriate modifications of the vectors (currently in
rogress) and/or by improvements in the quality of RNA
reparations and transfection procedure should result in
ncreased yields of VLPs. The titers of VLPs in some
xperiments were higher when assayed in Vero cells
Table 1). Interestingly, similar amounts of infectious
LPs were recovered from lysates of the doubly trans-
ected cells (results not shown), suggesting that cell
ysates can be used as additional source of VLPs.
Importantly, replication of all the recombinant KUN
eplicon RNAs (except C20DX/VSV-G/2Arep) in trans-
ected or VLP-infected BHK and Vero cells did not pro-
uce any apparent CPE (see Figs. 2, 3, and 5), which
onfirmed our previous observations on the noncyto-
athic nature of KUN replicons after prolonged incuba-
ion (15 days) of transfected cells and during multiple
assaging (68 passages) of G418 selected cells (Khro-
ykh and Westaway, 1997; Khromykh et al., 1998a,b).
ome initial signs of CPE were observed in cells at 48 h
fter transfection with C20DX/VSV-G/2Arep RNA (data
ot shown) and it was most likely due to the cytopathic
ature of the VSV-G protein (Chen et al., 1996).
stablishment of stable cell lines expressing CAT or
FP genes using C20DX2ArepNeo vector
Recently we described the preparation of a stable BHK
ell line persistently expressing dicistronic KUN-Neo
eplicon RNA (Khromykh and Westaway, 1997) and the
se of this cell line for complementation of defective KUN
enomes with deletions in the KUN RNA polymerase
ene NS5 (Khromykh et al., 1998b). In those studies we
emonstrated continuous replication of replicon RNA in
ells either after transfection with monocistronic C20rep
NA or after G418 selection of cells transfected with
icistronic DME/76Neo replicon. This was shown by di-
ect incorporation of appropriate labels into RNA and into
he expressed KUN NS3 protein as well as by accumu-
ation of KUN-specific RNA in Northern blot analysis
Khromykh and Westaway, 1997). To demonstrate the
tility of a dicistronic KUN-Neo replicon vector for the
stablishment of stable cell lines expressing FGs, we
repared two constructs, C20DX/CAT/2ArepNeo and
20DX/GFP/2ArepNeo, by cloning CAT and GFP se-
uences into the SpeI site of the C20DX2ArepNeo vector
Fig. 1A). Transfection of the in vitro transcribed RNAs
nto BHK21 cells and subsequent incubation of these
ells in medium supplemented with 1 mg/ml G418 re-
ulted in selection of cells expressing CAT and GFP
enes (repCAT-BHK and repGFP-BHK, respectively; Fig.
). Importantly, the level of CAT expression remained
table during further passaging of the repCAT-BHK cellsn the selection medium (Fig. 6B). WDISCUSSION
We have demonstrated that flavivirus KUN replicon
ectors can be used for transient or continuous expres-
ion of FGs in mammalian cells and confirmed our pre-
ious observations that replication of these vectors in
ells does not produce CPE. We also show that recom-
inant KUN replicon RNAs expressing FGs can be en-
apsidated into VLPs by subsequent transfection with
FV replicon RNA expressing KUN structural genes.
hese VLPs could be used for delivery of recombinant
elf-replicating RNAs into a wide range of cells or ani-
als leading to a long-term expression of heterologous
roteins. Importantly, because of the heterologous na-
ure of the developed packaging system, no recombina-
ion between KUN and SFV RNAs resulting in production
f an infectious virus can occur. The amounts of CAT and
-gal proteins produced using KUN replicon vectors
ere similar or only slightly lower than those produced
sing alphavirus replicon vectors (Figs. 3A and 3B). The
evels of b-gal expression from the SFV replicon in our
xperiments (;7–8 mg per 106 cells) were lower than
hose published by others in similar experiments (;60
g per 106 cells) (Berglund et al., 1998). This difference
ay be related to possible variations in the quality of
NA preparations and quantity of RNA used, transfection
fficiencies, cell populations, and conditions of the re-
orter assay. It is important to emphasize in this context
hat our comparative experiments with KUN and alpha-
irus recombinant replicon RNAs were performed in par-
llel, with the same amounts of RNA and under the same
onditions. Noticeably, replication of KUN replicons in
ontrast to alphavirus replicons did not produce any CPE
n cells (see Fig. 3, and see results in Khromykh and
FIG. 6. Stable BHK cell lines expressing GFP (repGFP-BHK) and CAT
repCAT-BHK). Cell lines were established by selection of BHK21 cells
ransfected with C20DX/GFP/2Arep and C20DX/CAT/2Arep RNAs, re-
pectively, in medium containing 1 mg/ml of G418 (Geneticin). (A) GFP
luorescence of passage 5 of repGFP-BHK cells. (B) Autoradiogram of
he CAT assay of the lysates from repCAT-BHK cells at passages 6 and
7. Both cell lines were maintained in the medium containing 1 mg/ml
f G418 (geneticin) during passaging.estaway, 1997), thus allowing expression of FGs over
l
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373KUNJIN REPLICON GENE EXPRESSION AND DELIVERY SYSTEMonger periods. This noncytopathic nature and persis-
ence of replication of KUN replicons allowed us to de-
elop a vector for the generation of stable cell lines
ontinuously expressing FGs by inserting an IRES-Neo
assette into the 39UTR of the C20DX2Arep replicon.
sing this selectable vector (C20DX2ArepNeo), stable
HK cell lines continuously expressing GFP and CAT
enes were rapidly established by selection of trans-
ected cells with antibiotic G418. The expression of the
AT gene in the established cell line was maintained at
he same level for at least 17 passages.
In attempt to develop a vaccine against HCV we ex-
ressed HCV Core and NS3 gene sequences in the KUN
eplicon vector. Both Core and NS3 genes were ex-
ressed well, but unexpectedly the packaging of replicon
NAs expressing HCV Core sequences into VLPs was
ot very efficient. It is not clear whether this inefficient
ackaging was caused by the altered secondary struc-
ure of the resulting recombinant replicon RNA or by
ompetition between HCV Core protein and KUN Core
rotein for binding to KUN replicon RNA. In contrast, the
ecombinant KUN replicon RNA expressing the HCV NS3
ene sequence was efficiently packaged into VLPs, and
e are planning to examine the immunogenic properties
f these VLPs in an animal model.
Very recently the development of new noncytopathic
IN replicon vectors was described (Agapov et al., 1998).
hese vectors were derived by selection from mutants
dapted for noncytopathic replication in BHK cells and
ere used for expression of FGs in transfected BHK
ells, in Chinese hamster ovary cells, and (less effi-
iently) in Vero cells, but failed to replicate in several
ther cell lines. In contrast to these SIN vectors, KUN
eplicon vectors are naturally noncytopathic and do not
ave to be adapted to a particular cell line. In preliminary
xperiments KUN replicon vectors were able to replicate
n a wide range of cell lines from different hosts including
amster, swine, monkey, mouse, and humans (Plaetinck
nd Khromykh, unpublished results). In addition, the abil-
ty of KUN noncytopathic replicons to be packaged into
LPs provides a more efficient way to deliver KUN rep-
icon vectors in vitro and especially in vivo. Thus we
elieve that the noncytopathic KUN replicon-based ex-
ression and delivery system should provide a useful
lternative to the existing alphavirus and poliovirus rep-
icon-based expression systems. Furthermore, the sys-
em could be useful in gene therapy applications for
elivery of genes to nondividing cells, where cell death is
ot desirable.
MATERIALS AND METHODS
ells
BHK21 cells were grown in Dulbecco’s modification of
inimal essential medium (DMEM, Gibco BRL) supple-
ented with 10% fetal bovine serum (FBS). Vero cells Here grown in M199 medium (Gibco BRL) supplemented
ith 5% FBS.
onstruction of the plasmids
(i) C20DX2Arep and C20DX2ArepNeo. The KUN repli-
on cDNA constructs C20DX2Arep and C20DX2ArepNeo
ere prepared by cloning the FMDV-2A sequence, PCR
mplified from the plasmid pT3CAT2A/NamodII (Percy et
l., 1994) (obtained from Peter Palese, Mt. Sinai School of
edicine, New York), using a forward primer with incor-
orated MluI–SpeI restriction sites and a reverse primer
ith incorporated EagI–MluI restriction sites, into the
scI site of the previously described C20DXrep and
20DXrepNeo plasmids (Khromykh et al., 1998a), respec-
ively (Fig. 1A). High-fidelity Pfu DNA polymerase (Strat-
gene) was used in all PCRs.
(ii) C20DX/CAT/2Arep and C20DX/CAT/2ArepNeo. The
MDV-2A-CAT sequence was PCR amplified from the
lasmid pT3CAT2A/NamodII (Percy et al., 1994) by using
he same reverse primer as for FMDV-2A amplification
nd a forward primer with an incorporated MluI restric-
ion site and then cloned into the AscI site of the
20DXrep and C20DXrepNeo plasmids to obtain C20DX/
AT/2Arep and C20DX/CAT/2ArepNeo constructs, re-
pectively.
(i i i) C20DXIRESrep and C20DX/CAT/IRESrep.
20DXIRESrep was constructed by cloning an EMCV
RES sequence, PCR amplified from the DME/76Neo
lasmid (Khromykh and Westaway, 1997) using the ap-
ropriate primers with incorporated AscI (forward
rimer) and MluI (reverse primer) restriction sites, into
he AscI site of the C20DXrep plasmid. The C20DX/CAT/
RESrep construct was prepared by cloning the CAT
ene, PCR amplified from the plasmid pT3CAT2A/
amodII (Percy et al., 1994) using primers with incorpo-
ated MluI restriction sites, into the AscI site of the
20DXIRESrep plasmid (Fig. 1C).
(iv) C20DX/GFP/2Arep, C20DX/GFP/2ArepNeo, C20DX/
cv-trCore/2Arep, C20DX/hcv-flCore/2Arep, C20DX/hcvNS3/
Arep, C20DX/VSV-G/2Arep, and C20DX/b-gal/2Arep. All
hese constructs were prepared in a similar way as
ollows. The heterologous genes were PCR amplified
rom corresponding plasmids using primers with incor-
orated SpeI and/or XbaI restriction sites (sequences of
he primers may be obtained from the corresponding
uthor) and cloned into the SpeI site of C20DX2Arep or
20DX2ArepNeo (Fig. 1A). Plasmids for PCR amplifica-
ions of the above genes were as follows: for GFP,
EGFP (Clontech); for hcv Core, pcDNA3/HCV-core (ob-
ained from Eric Gowans, Sir Albert Sakzewski Virus
esearch Center, Brisbane, Australia); for hcvNS3, p3B-
71 (obtained from Eric Gowans); for VSV-G, pHCMV19
obtained from Michael Bruns, Heinrich-Pette-Institut,
amburg, Germany); for b-gal, pSFV3/LacZ (Gibco BRL).
Rr
B
K
(
I
p
a
f
R
f
a
B
v
I
b
w
t
t
w
E
t
C
r
d
C
i
c
t
t
a
P
d
m
p
a
p
a
p
p
a
s
C
B
A
A
B
B
C
C
C
F
F
J
K
K
K
K
K
L
L
L
374 VARNAVSKI AND KHROMYKHNA transcription, electroporation, and infection
Preparation of the recombinant KUN, SIN, and SFV
eplicon RNAs, electroporation of these RNAs into
HK21 cells, and infection of BHK21 and Vero cells with
UN VLPs were performed as described previously
Khromykh and Westaway, 1997; Khromykh et al., 1998a).
mmunofluorescence analysis
IF analysis of electroporated or infected cells was
erformed as described previously (Khromykh and West-
way, 1997; Khromykh et al., 1998a) using cold acetone
ixation and antibodies specific for expressed proteins.
abbit polyclonal anti-CAT antibodies were purchased
rom 5 Prime 3 3 Prime (Boulder, CO), rabbit polyclonal
nti-VSV-G antibodies were obtained from Michael
runs, and human anti-HCV polyclonal serum was pro-
ided by Eric Gowans.
n situ b-galactosidase reaction staining and
-galactosidase assay
X-gal staining of BHK21 cells either electroporated
ith C20DX/b-gal/2Arep RNA or infected with VLP con-
aining encapsidated C20DX/b-gal/2Arep RNA and de-
ermination of b-galactosidase activity in the cell lysates
ere performed using a commercial b-Galactosidase
nzyme Assay System (Promega, Madison, WI), essen-
ially as described by the manufacturer.
AT assay
CAT activity in the lysates of BHK21 cells electropo-
ated with SIN replicon TRCAT (obtained from Peter Bre-
enbeek, Institute of Virology, Leiden, Netherlands) and
20DX/CAT/2Arep RNAs or infected with VLPs contain-
ng encapsidated C20DX/CAT/2Arep RNA or in a stable
ell line expressing C20DX/CAT/2ArepNeo RNA was de-
ermined using thin-layer chromatography or liquid scin-
illation count assays as described previously (Khromykh
nd Westaway, 1997).
reparation of encapsidated particles and
etermination of their titer
Preparation of the recombinant KUN VLPs and deter-
ination of their titers were performed by counting IF-
ositive or X-gal stained cells after infection with the
ppropriate dilution of VLPs, essentially as described
reviously (Khromykh et al., 1998a).
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